Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
17.40
-2.79 (-13.82%)
At close: Jun 27, 2025, 4:00 PM
16.85
-0.55 (-3.16%)
After-hours: Jun 27, 2025, 7:59 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $8.60 billion as of June 27, 2025. Its market cap has increased by 11,987.78% in one year.
Market Cap
8.60B
Enterprise Value
8.60B
1-Year Change
11,987.78%
Ranking
Category
Stock Price
$17.40
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $8.60B, an increase of 7,064.12%. That is a compound annual growth rate of 195.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 9.98B | 15,430.77% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.28B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 215.99B |